392 related articles for article (PubMed ID: 33450541)
1. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
[TBL] [Abstract][Full Text] [Related]
2. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
3. The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids.
Chen D; Lu S; Yang G; Pan X; Fan S; Xie X; Chen Q; Li F; Li Z; Wu S; He J
Biochem Pharmacol; 2020 Jul; 177():113982. PubMed ID: 32305436
[TBL] [Abstract][Full Text] [Related]
4. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
5. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
Liu YM; Shahed-Al-Mahmud M; Chen X; Chen TH; Liao KS; Lo JM; Wu YM; Ho MC; Wu CY; Wong CH; Jan JT; Ma C
Cell Rep; 2020 Aug; 32(6):108016. PubMed ID: 32755598
[TBL] [Abstract][Full Text] [Related]
6. 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses.
Colpitts CC; Ustinov AV; Epand RF; Epand RM; Korshun VA; Schang LM
J Virol; 2013 Apr; 87(7):3640-54. PubMed ID: 23283943
[TBL] [Abstract][Full Text] [Related]
7. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
[TBL] [Abstract][Full Text] [Related]
9. An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.
O'Hanlon R; Leyva-Grado VH; Sourisseau M; Evans MJ; Shaw ML
ACS Infect Dis; 2019 Oct; 5(10):1779-1793. PubMed ID: 31448902
[TBL] [Abstract][Full Text] [Related]
10. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
[TBL] [Abstract][Full Text] [Related]
11. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
13. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of enveloped viruses infectivity by curcumin.
Chen TY; Chen DY; Wen HW; Ou JL; Chiou SS; Chen JM; Wong ML; Hsu WL
PLoS One; 2013; 8(5):e62482. PubMed ID: 23658730
[TBL] [Abstract][Full Text] [Related]
15. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
16. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
Manna S; Chowdhury T; Baindara P; Mandal SM
Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.
Jang Y; Shin H; Lee MK; Kwon OS; Shin JS; Kim YI; Kim CW; Lee HR; Kim M
Sci Rep; 2021 Jan; 11(1):821. PubMed ID: 33436985
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
[TBL] [Abstract][Full Text] [Related]
19. Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant
Saito S; Funayama K; Kato W; Okuda M; Kawamoto M; Matsubara T; Sato T; Sato A; Otsuguro S; Sasaki M; Orba Y; Sawa H; Maenaka K; Shindo K; Imoto M; Arai MA
J Nat Prod; 2022 Nov; 85(11):2583-2591. PubMed ID: 36223390
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.
Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
